2022 ICD-10-CM Diagnosis Code D07.2

Carcinoma in situ of vagina

    2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
  • D07.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2022 edition of ICD-10-CM D07.2 became effective on October 1, 2021.
  • This is the American ICD-10-CM version of D07.2 - other international versions of ICD-10 D07.2 may differ.
Applicable To
  • Severe dysplasia of vagina
  • Vaginal intraepithelial neoplasia III [VAIN III]
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D07.2. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • moderate dysplasia of vagina (
    ICD-10-CM Diagnosis Code N89.1

    Moderate vaginal dysplasia

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Applicable To
    • Vaginal intraepithelial neoplasia [VAIN], grade II
    N89.1
    )
  • vaginal intraepithelial neoplasia II [VIN II] (
    ICD-10-CM Diagnosis Code N89.1

    Moderate vaginal dysplasia

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Applicable To
    • Vaginal intraepithelial neoplasia [VAIN], grade II
    N89.1
    )
The following code(s) above D07.2 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D07.2:
  • C00-D49
    2022 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2022 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
  • D07
    ICD-10-CM Diagnosis Code D07

    Carcinoma in situ of other and unspecified genital organs

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • melanoma in situ of trunk (D03.5)
    Carcinoma in situ of other and unspecified genital organs
Approximate Synonyms
  • Cancer in situ of vagina
  • Severe dysplasia of vagina
Clinical Information
  • Stage 0 includes: (tis, n0, m0). Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th ed.)
  • Stage 0 includes: (tis, n0, m0). Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th ed.)-2003
ICD-10-CM D07.2 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
  • 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
  • 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
  • 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
  • 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
  • 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
  • 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
  • 754 Malignancy, female reproductive system with mcc
  • 755 Malignancy, female reproductive system with cc
  • 756 Malignancy, female reproductive system without cc/mcc

Convert D07.2 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
Code annotations containing back-references to D07.2:
  • Type 1 Excludes: R87.62
    , R87.62
    , R87.62
    , R87.7
    , R87.7
    , N89
    , N89
    , N89
    , C52
    ICD-10-CM Diagnosis Code R87.62

    Abnormal cytological findings in specimens from vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from cervix uteri (R87.61-)
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • carcinoma in situ of vagina (histologically confirmed) (D07.2)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    Type 2 Excludes
    • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
    • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
    Use Additional
    • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
    ICD-10-CM Diagnosis Code R87.62

    Abnormal cytological findings in specimens from vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from cervix uteri (R87.61-)
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • carcinoma in situ of vagina (histologically confirmed) (D07.2)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    Type 2 Excludes
    • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
    • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
    Use Additional
    • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
    ICD-10-CM Diagnosis Code R87.62

    Abnormal cytological findings in specimens from vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal cytological findings in specimens from cervix uteri (R87.61-)
    • abnormal cytological findings in specimens from other female genital organs (R87.69)
    • carcinoma in situ of vagina (histologically confirmed) (D07.2)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    Type 2 Excludes
    • vaginal high risk human papillomavirus (HPV) DNA test positive (R87.811)
    • vaginal low risk human papillomavirus (HPV) DNA test positive (R87.821)
    Use Additional
    • code to identify acquired absence of uterus and cervix, if applicable (Z90.71-)
    ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    ICD-10-CM Diagnosis Code R87.7

    Abnormal histological findings in specimens from female genital organs

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
    Type 1 Excludes
    • carcinoma in situ (histologically confirmed) of female genital organs (D06-D07.3)
    • cervical intraepithelial neoplasia I [CIN I] (N87.0)
    • cervical intraepithelial neoplasia II [CIN II] (N87.1)
    • cervical intraepithelial neoplasia III [CIN III] (D06.-)
    • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
    • dysplasia (mild) (moderate) of vagina (histologically confirmed) (N89.-)
    • vaginal intraepithelial neoplasia I [VAIN I] (N89.0)
    • vaginal intraepithelial neoplasia II [VAIN II] (N89.1)
    • vaginal intraepithelial neoplasia III [VAIN III] (D07.2)
    • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
    • severe dysplasia of vagina (histologically confirmed) (D07.2)
    ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    ICD-10-CM Diagnosis Code N89

    Other noninflammatory disorders of vagina

      2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal results from vaginal cytologic examination without histologic confirmation (R87.62-)
    • carcinoma in situ of vagina (D07.2)
    • HGSIL of vagina (R87.623)
    • inflammation of vagina (N76.-)
    • senile (atrophic) vaginitis (N95.2)
    • severe dysplasia of vagina (D07.2)
    • trichomonal leukorrhea (A59.00)
    • vaginal intraepithelial neoplasia [VAIN], grade III (D07.2)
    ICD-10-CM Diagnosis Code C52

    Malignant neoplasm of vagina

      2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Female Dx
    Type 1 Excludes
    • carcinoma in situ of vagina (D07.2)

Diagnosis Index entries containing back-references to D07.2:
  • Dysplasia - see also Anomaly
    • vagina N89.3
      ICD-10-CM Diagnosis Code N89.3

      Dysplasia of vagina, unspecified

        2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
      • severe NEC D07.2
  • Neoplasia
    • intraepithelial (histologically confirmed)
      • vagina (histologically confirmed) (VAIN) N89.3
        ICD-10-CM Diagnosis Code N89.3

        Dysplasia of vagina, unspecified

          2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
        • grade III D07.2 (severe dysplasia)

ICD-10-CM Codes Adjacent To D07.2
D05.91 Unspecified type of carcinoma in situ of right breast
D05.92 Unspecified type of carcinoma in situ of left breast
D06 Carcinoma in situ of cervix uteri
D06.0 Carcinoma in situ of endocervix
D06.1 Carcinoma in situ of exocervix
D06.7 Carcinoma in situ of other parts of cervix
D06.9 Carcinoma in situ of cervix, unspecified
D07 Carcinoma in situ of other and unspecified genital organs
D07.0 Carcinoma in situ of endometrium
D07.1 Carcinoma in situ of vulva
D07.2 Carcinoma in situ of vagina
D07.3 Carcinoma in situ of other and unspecified female genital organs
D07.30 Carcinoma in situ of unspecified female genital organs
D07.39 Carcinoma in situ of other female genital organs
D07.4 Carcinoma in situ of penis
D07.5 Carcinoma in situ of prostate
D07.6 Carcinoma in situ of other and unspecified male genital organs
D07.60 Carcinoma in situ of unspecified male genital organs
D07.61 Carcinoma in situ of scrotum
D07.69 Carcinoma in situ of other male genital organs
D09 Carcinoma in situ of other and unspecified sites

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.